Select Publications
Journal articles
2004, 'Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die', Journal of Cell Biology, 165, pp. 835 - 842, http://dx.doi.org/10.1083/jcb.200312031
,2004, 'Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9', Journal of Cell Biology, 165, pp. 775 - 780, http://dx.doi.org/10.1083/jcb.200312030
,2004, 'Caspase-8 Levels Affect Necessity for Mitochondrial Amplification in Death Ligand-Induced Glioma Cell Apoptosis', Molecular Carcinogenesis, 39, pp. 173 - 182, http://dx.doi.org/10.1002/mc.20011
,2004, 'Unlike Diablo/smac, Grim Promotes Global Ubiquitination and Specific Degradation of X Chromosome-linked Inhibitor of Apoptosis (XIAP) and Neither Cause Apoptosis', Journal of Biological Chemistry, 279, pp. 4313 - 4321, http://dx.doi.org/10.1074/jbc.M305661200
,2003, 'Insights into the pathogenesis of cerebral lesions in incontinentia pigmenti', Pediatric Neurology, 29, pp. 148 - 150, http://dx.doi.org/10.1016/S0887-8994(03)00150-4
,2002, 'A novel Apaf-1-independent putative caspase-2 activation complex', Journal of Cell Biology, 159, pp. 739 - 745, http://dx.doi.org/10.1083/jcb.200209004
,2002, 'The p35 relative, p49, inhibits mammalian and Drosophila caspases including DRONC and protects againts apoptosis', Cell Death and Differentiation, 9, pp. 1311 - 1320, http://dx.doi.org/10.1038/sj.cdd.4401135
,2002, 'Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome', Nature, 419, pp. 634 - 637, http://dx.doi.org/10.1038/nature01101
,2002, 'The anti-apoptotic activity of XIAP is retained upon mutation of both the caspase 3- and caspase 9-interacting sites', Journal of Cell Biology, 157, pp. 115 - 124, http://dx.doi.org/10.1083/jcb.200108085
,2002, 'HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins', Journal of Biological Chemistry, 277, pp. 445 - 454, http://dx.doi.org/10.1074/jbc.M109891200
,2002, 'Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9', Cell Death and Differentiation, 9, pp. 832 - 841, http://dx.doi.org/10.1038/sj.cdd.4401033
,2001, 'Analysis of candidate antagonists of IAP-mediated caspase inhibition using yeast reconstituted with the mammalian Apaf-1-activated apoptosis mechanism', Apoptosis, 6, pp. 331 - 338, http://dx.doi.org/10.1023/A:1011329917895
,2001, 'Till death do us part', Cell Death and Differentiation, 8, pp. 662 - 664, http://dx.doi.org/10.1038/sj.cdd.4400895
,2001, 'Direct inhibition of caspase 3 is dispensable for the anti-apoptotic activity of XIAP', EMBO Journal, 20, pp. 3114 - 3123, http://dx.doi.org/10.1093/emboj/20.12.3114
,2001, 'DIABLO promotes apoptosis by removing MIHA/XIAP from processed caspase 9', Journal of Cell Biology, 153, pp. 483 - 490, http://dx.doi.org/10.1083/jcb.152.3.483
,2001, 'Upper cervical spinal cord injury in neonates: The use of magnetic resonance imaging', Journal of Pediatrics, 138, pp. 105 - 108, http://dx.doi.org/10.1067/mpd.2001.109195
,2000, 'Sequence as well as functional similarity for DIABLO/Smac and Grim, Reaper and Hid? [3]', Cell Death and Differentiation, 7, pp. 1275, http://dx.doi.org/10.1038/sj.cdd.4400790
,2000, 'Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins', Cell, 102, pp. 43 - 53, http://dx.doi.org/10.1016/S0092-8674(00)00009-X
,1999, 'Winter Use of Large-leafed Privet Ligustrum lucidum (Family: Oleaceae) by Birds in Suburban Lismore, New South Wales', Proceedings of the Linnean Society of New South Wales, 1999, pp. 29 - 38
,1999, 'Nerve growth factor signaling through p75 induces apoptosis in Schwann cells via a Bcl-2-independent pathway', Journal of Neuroscience, 19, pp. 4828 - 4838, http://dx.doi.org/10.1523/jneurosci.19-12-04828.1999
,1999, 'Inhibition of apoptosis and clonogenic survival of cells expressing crmA variants: Optimal caspase substrates are not necessarily optimal inhibitors', EMBO Journal, 18, pp. 330 - 338, http://dx.doi.org/10.1093/emboj/18.2.330
,1999, 'Caspase inhibitors', Cell Death and Differentiation, 6, pp. 1081 - 1086, http://dx.doi.org/10.1038/sj.cdd.4400594
,1998, 'Anti-apoptotic potential of insect cellular and viral IAPs in mammalian cells', Cell Death and Differentiation, 5, pp. 569 - 576, http://dx.doi.org/10.1038/sj.cdd.4400389
,1998, 'Intussusception and appendiceal mucocele in a child with cystic fibrosis', Archives de Pediatrie, 5, pp. 400 - 403, http://dx.doi.org/10.1016/S0929-693X(98)80027-4
,1998, 'Base Deficit (BD) in Babies with Post-asphyxial Hypoxic Ischemic Encephalopathy (PA-HIE) and relationship to Outcome 1107', Pediatric Research, 43, pp. 190 - 190, http://dx.doi.org/10.1203/00006450-199804001-01128
,1998, 'Cloning and testing new genes to block specific caspase family members.† 998', Pediatric Research, 43, pp. 172 - 172, http://dx.doi.org/10.1203/00006450-199804001-01019
,1998, 'Predicting the Outcome of Postasphyxial Hypoxic-Ischemic Encephalopathy Within 4 Hours of Birth', Obstetrical & Gynecological Survey, 53, pp. 409 - 410, http://dx.doi.org/10.1097/00006254-199807000-00011
,1997, 'Clinicopathological correlations in postasphyxial organ damage: A donor organ perspective', Pediatrics, 99, pp. 797 - 799, http://dx.doi.org/10.1542/peds.99.6.797
,1997, 'Dexamethasone prevents apoptosis in a neonatal rat model of hypoxic-ischemic encephalopathy (HIE) by a reactive oxygen species-independent mechanism', Brain Research, 747, pp. 9 - 17, http://dx.doi.org/10.1016/S0006-8993(96)01201-2
,1997, 'Motor neurone disease and the life of motor neurones', MEDICAL JOURNAL OF AUSTRALIA, 166, pp. 109 - 109, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WE11200025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1997, 'Apoptosis and the immune system', British Medical Bulletin, 53, pp. 591 - 603, http://dx.doi.org/10.1093/oxfordjournals.bmb.a011632
,1997, 'Apoptosis, haemopoiesis and leukaemogenesis', Bailliere's Clinical Haematology, 10, pp. 561 - 576, http://dx.doi.org/10.1016/S0950-3536(97)80026-1
,1997, 'Early Somatosensory Evoked Potentials in Preterm Infants: Their Prognostic Utility', Neonatology, 71, pp. 83 - 91, http://dx.doi.org/10.1159/000244401
,1997, 'Predicting the outcome of postasphyxial hypoxic-ischemic encephalopathy within 4 hours of birth', Journal of Pediatrics, 131, pp. 613 - 617, http://dx.doi.org/10.1016/S0022-3476(97)70072-6
,1997, 'Visual evoked potentials for prediction of neurodevelopmental outcome in preterm infants', Neonatology, 71, pp. 148 - 155, http://dx.doi.org/10.1159/000244410
,1996, 'Preterm maturation of the somatosensory evoked potential', Electroencephalography and Clinical Neurophysiology - Evoked Potentials, 100, pp. 448 - 452, http://dx.doi.org/10.1016/0168-5597(96)95218-1
,1996, 'DEXAMETHASONE NEUROPROTECTION IS ASSOCIATED WITH PRESERVED EXPRESSION OF BCL-2 AND SUPPRESSION OF GLIAL FIBRILLARY ACID PROTEIN (GFAP). ▴ 1226', Pediatric Research, 39, pp. 207 - 207, http://dx.doi.org/10.1203/00006450-199604001-01248
,1996, 'DEXAMETHASONE PREVENTS APOPTOSIS IN A RAT MODEL OF NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY (HIE) BY A FREE RADICAL INDEPENDENT MECHANISM. ▴ 1227', Pediatric Research, 39, pp. 207 - 207, http://dx.doi.org/10.1203/00006450-199604001-01249
,1996, 'SERUM TRANSAMINASE MEASUREMENTS IN POST-ASPHYXIAL (PA) HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE). 1743', Pediatric Research, 39, pp. 293 - 293, http://dx.doi.org/10.1203/00006450-199604001-01767
,1994, 'Associations of urachal abnormalities: Does patency of the urachus occur because of distal urinary tract obstruction?', Pediatric Surgery International, 9, pp. 381 - 382, http://dx.doi.org/10.1007/BF01686007
,1994, 'Prediction of severe adverse outcome after moderate or severe birth asphyxia', Pediatric Neurology, 11, pp. 81 - 81, http://dx.doi.org/10.1016/0887-8994(94)90146-5
,1991, 'Hepatic cholesterol ester storage disease: Two new cases diagnosed in adults', Gastroenterologie Clinique et Biologique, 15, pp. 441 - 444
,1990, 'CHRONIC-PANCREATITIS', GAZETTE MEDICALE, 97, pp. 41 - 44, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1990EA70500008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1989, 'Epithelial bridging on burn patients following primary excision and grafting', Burns, 15, pp. 129 - 131, http://dx.doi.org/10.1016/0305-4179(89)90145-9
,1988, 'Three patients with carbon monoxide poisoning treated with hyperbaric oxygen therapy', Journal of Paediatrics and Child Health, 24, pp. 194 - 196, http://dx.doi.org/10.1111/j.1440-1754.1988.tb00324.x
,Conference Papers
2024, 'Phosphoproteomic profiling for novel target identification in childhood sarcomas: Paving the road towards improved outcomes for relapsed and metastatic osteosarcoma', Sydney, Australia, presented at ZERO Childhood Cancer National Symposium “Precision in Action: Collaboration Driving Cancer Breakthroughs”, Sydney, Australia, 08 May 2024
,2023, 'Phosphoproteomic profiling for novel target identification in childhood sarcomas: Paving the road towards improved outcomes for relapsed and metastatic osteosarcoma', Melbourne (Cape Schanck), presented at Cell Signalling and its Therapeutic Implications (CSTI 2023), Melbourne (Cape Schanck), 15 May 2023, https://drive.google.com/file/d/1G0HeWsknc2z2W3Tq0rTQkECg4SLzgTsO/view
,2021, 'Analysis of DNA minimal residual disease markers in pediatric solid cancers using quantitative real time PCR and droplet digital PCR', in Analysis of DNA minimal residual disease markers in pediatric solid cancers using quantitative real time PCR and droplet digital PCR, American Association for Cancer Research (AACR), pp. 639 - 639, presented at AACR 2021, http://dx.doi.org/10.1158/1538-7445.AM2021-639
,2018, 'Combined BCL-2 and HDAC Targeting Has Potent and TP53 Independent Activity in AML', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, presented at 60th Annual Meeting of the American-Society-of-Hematology (ASH), CA, San Diego, 01 December 2018 - 04 December 2018, http://dx.doi.org/10.1182/blood-2018-99-117403
,2018, 'Different Classes of ABL1 Fusions Activate Different Downstream Signalling Nodes', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, presented at 60th Annual Meeting of the American-Society-of-Hematology (ASH), CA, San Diego, 01 December 2018 - 04 December 2018, http://dx.doi.org/10.1182/blood-2018-99-117844
,